October 2022: Comparing dedicated and designated approaches to integrating task-shared psychological interventions into chronic disease care in South Africa: a three-arm, cluster randomised, multicentre, open-label trial

Nov 2, 2022

Article and Study Summary: Comparing dedicated and designated approaches to integrating task-shared psychological interventions into chronic disease care in South Africa: a three-arm, cluster randomised, multicentre, open-label trial Published in: Lancet. 2022; 400...

“They are our eyes outside there in the community”: Implementing enhanced training, management and monitoring of South Africa’s ward-based primary healthcare outreach teams

Sep 7, 2022

Abstract: Introduction: In 2018, South Africa’s National Department of Health provided additional resources for ward-based primary healthcare outreach teams (OT) with support from the U.S. President’s Emergency Plan for AIDS Relief. The intervention...

May/June 2022: Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

Jul 6, 2022

Article and Study Summary: Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial Published in: Lancet. 2022;399(10337):1779-1789 https://doi.org/10.1016/S0140-6736(22)00538-4 Authors: Delany-Moretlwe S, Hughes...

April 2022: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis

Apr 29, 2022

Article and Study Summary: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis Published in: New England Journal of Medicine 2022;386(12):1109-1120 https://www.nejm.org/doi/full/10.1056/NEJMoa2111904 Authors: Jarvis JN, Lawrence DS, Meya DB, et...

Women’s Perceptions Of HIV- And Sexuality-Related Stigma in Relation to Prep: Qualitative Findings from The Masibambane Study, Durban, South Africa

Mar 10, 2022

Authors: S Bergam, A D Harrison, N Benghu, S Khumalo, N Tesfay, T Exner, L Miller, C Dolezal, J Hanass-Hancock, S Hoffman Daily oral pre-exposure prophylaxis (PrEP) offers effective HIV prevention. In South Africa, PrEP is publicly available, but use among young women...

South Africa